Rubin, Zachary A.
Martin, Elise M.
Allyn, Paul
Article History
First Online: 29 June 2018
Compliance with Ethical Standards
:
: Zachary Rubin and Elise Martin are receiving research funding from Pfizer for an ongoing clinical trial on a CDI vaccine. Paul Allyn owns stock in Pfizer.
: This article cites one study with human subjects performed by Zachary Rubin, which previously was reviewed and approved by the local IRB. All other studies cited with human or animal subjects were not performed by any of the authors.